Menu ×

Healthcare & Pharmaceutical

Immunotherapy Drug Market : Global Demand Analysis & Opportunity Outlook 2021

  • Report ID: 60

Overview

Immunotherapy also referred as biologic therapy is a kind of treatment which is designed to enhance human immunity system to fight against cancer. Immunotherapy restores or improves immunity system to restrict growth of cancer cells, preventing it to spread to other parts of the body and also enables the immunity system to destroy cancer cells from the body.   

Global Immunotherapy Drug market is envisioned to exhibit a compound annual growth rate (CAGR) of 13.0% during 2015-2021.

Market Size and Forecast

North America is believed to hold the first rank in global immunotherapy drug market during 2015-2021. It is projected that in 2016, 1.7 million new cancer cases would be detected in the U.S., making the country a major market for immunotherapy drugs in North America. The immunotherapy drug market in the region is also believed to spurt from higher spending on health care sector.

Western Europe immunotherapy drug market is also expected to witness a promising growth sparked by rising cases of lung cancer, which is responsible for 215 of all cancer mortalities in the European region.

Asia-Pacific immunotherapy drug market is likely to behold the highest CAGR during the forecast period i.e. 2015-2021. Rising per capita income and increasing investments on healthcare infrastructure are some of the major factors which are projected to bolster Immunotherapy Drug market in countries such as India and China. CLICK TO DOWNLOAD FREE SAMPLE

Market Segmentation

By Drug Types

Based on types, global Immunotherapy Drug market can be segmented into:

  • Antibodies
  • Interleukins
  • Interferon
  • Checkpoint Inhibitors
  • Vaccines

By Region

  • North America (United States, Canada), Market size, Y-O-Y growth Market size, Y-O-Y growth & Opportunity Analysis, Future forecast & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX (Belgium, Netherlands, Luxembourg), NORDIC (Norway, Denmark, Sweden, Finland), Poland, Russia, Rest of Europe), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa), Market size, Y-O-Y growth, Future forecast & Opportunity Analysis

Growth Drivers and challenges

Rising incidences of cancer across the globe coupled with increasing inclination towards cancer treatments with lesser side effects are believed to augment the growth of global immunotherapy drug market in future.

In addition to that, escalation of approval process in cancer related drugs is also expected to drive the global immunotherapy drug market over the forecast period i.e. 2015-2021.

However, high cost associated with immunotherapy devices along with lack of awareness of biologic cancer therapy is anticipated to hamper the growth of global immunotherapy drug market over next few years.

Key Players

Global Immunotherapy Drug market includes some of the major players such as AbbVie Inc., Amgen Inc., Novartis International Ag, F. Hoffmann-La Roche Ltd, Merck, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Johnson & Johnson Services Inc, AstraZeneca plc, Pfizer Inc.

 

Factors Covered for Market Penetration
Factors to be Considered for maximum ROI
Connect with our Analyst

Privacy Policy | Terms & Conditions

Copyright © 2019 Research Nester. All Rights Reserved